Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Minority Interest (2019 - 2024)

Arcadia Biosciences filings provide 6 years of Minority Interest readings, the most recent being -$138000.0 for Q3 2024.

  • On a quarterly basis, Minority Interest changed 0.0% to -$138000.0 in Q3 2024 year-over-year; TTM through Sep 2024 was -$138000.0, a 0.0% change, with the full-year FY2023 number at -$138000.0, down 3.76% from a year prior.
  • Minority Interest hit -$138000.0 in Q3 2024 for Arcadia Biosciences, roughly flat from -$138000.0 in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $1.5 million in Q2 2020 to a low of -$138000.0 in Q2 2023.
  • Median Minority Interest over the past 5 years was -$39000.0 (2022), compared with a mean of $303789.5.
  • Biggest five-year swings in Minority Interest: surged 33.17% in 2020 and later plummeted 600.0% in 2023.
  • Arcadia Biosciences' Minority Interest stood at $827000.0 in 2020, then tumbled by 87.55% to $103000.0 in 2021, then plummeted by 229.13% to -$133000.0 in 2022, then fell by 3.76% to -$138000.0 in 2023, then changed by 0.0% to -$138000.0 in 2024.
  • The last three reported values for Minority Interest were -$138000.0 (Q3 2024), -$138000.0 (Q2 2024), and -$138000.0 (Q1 2024) per Business Quant data.